Michigan Picks Up Pace of Reviewing and Awarding Marijuana Business Licenses

Michigan Picks Up Pace of Reviewing and Awarding Marijuana Business Licenses

LANSING – Since the Michigan Medical Marijuana Licensing Board was abolished at the end of April, the Marijuana Regulatory Agency has dramatically picked up the pace of reviewing business applications.

In May, the first full month of taking over licensing responsibilities, the MRA reviewed, and either approved, denied or gave preliminary approval to 213 license applications. In contrast, the licensing board, which was abolished earlier this year by Gov. Gretchen Whitmer, was considering an average of 95 applications a month.

As the state’s legal marijuana market for adult recreational use starts later this year, quick and efficient licensing will ensure that the market succeeds and thrives, MRA director Andrew Brisbo said Thursday, after the first public meeting of the MRA. 

Read more

Published at Fri, 14 Jun 2019 14:41:00 +0000

Vapen MJ Ventures Announces Listing on Frankfurt Stock Exchange

Vapen MJ Ventures Announces Listing on Frankfurt Stock Exchange

Vapen MJ Ventures (CSE: VAPN) (“Vapen MJ”) a fully integrated agricultural technology, services and property management company in the regulated cannabis industry, today announced that its common shares are now listed on the Frankfurt Stock Exchange (FSE) trading under the ticker symbol “VV5”. The Company continues to be listed on the Canadian Securities Exchange (CSE) under the ticker symbol “VAPN”.

Bob Brilon, president and chief financial officer of Vapen MJ Ventures, commented, “Listing the common shares of Vapen MJ Ventures on the Frankfurt Exchange is another important step in our evolution, helping increase awareness of our progress with the global investor community. The cannabis markets continue to expand around the world, and Vapen MJ is increasingly well-positioned to benefit from this growth. We recently announced our expansion outside of Arizona, with a partnership in Kentucky, and we expect additional progress in our efforts to diversify our revenues internationally. This listing is an obvious next step in our global expansion.”

About Vapen MJ Ventures

Vapen MJ, through its wholly-owned subsidiaries, currently operates in the US as an agricultural technology, services and property management company utilizing a full vertical integration business model to oversee and execute all aspects of cultivation, extraction, manufacturing (THC and CBD cartridges, concentrates, edibles), retail dispensary, and wholesale distribution of high margin Cannabis THC and Hemp CBD products under the Vapen Brand.  Vapen MJ expansion plans include partnering with cannabis license holders and hemp farms in multiple states within the US.

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Vapen MJ’ periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to future developments and the business and operations of Vapen MJ.

Although Vapen MJ has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; are engaged in activities currently considered illegal under U.S. Federal laws; change in laws; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Vapen MJ disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Vapen MJ does not assume any liability for disclosure relating to any other company mentioned herein.

SOURCE Vapen MJ Ventures Corporation

View original content: http://www.newswire.ca/en/releases/archive/June2019/14/c9310.html

Bob Brilon, President and CFO, T: 602-620-9725, Investors@VapenMJ.comCopyright CNW Group 2019

Published at Fri, 14 Jun 2019 13:11:52 +0000

Why Mood-Based Cannabis Products Are About to Blowup

Why Mood-Based Cannabis Products Are About to Blowup

eCann Media is proud to showcase our portfolio of investments and subsidiaries. We have completed numerous investments across multiple verticals and sectors in the cannabis industry. Requesting an invitation will enable the eCann team to consider your eligibility for investment as well help us to identify the opportunities that best fit your needs and investment objectives.

Published at Fri, 14 Jun 2019 18:00:00 +0000

Marijuana Stocks Review

Marijuana Stocks Review

The marijuana industry has grown by leaps and bounds over the past year or so, primarily due to the legalization in Canada and in parts of the United States. The formation of the industry and the listing of stocks from many of the leading companies which have also made it possible for investors to put their money into a growing sector.

Some investors might prefer stocks which are on a strong streak of gains, while others might prefer a stock that are beaten down and could be primed for a surge soon. In such a situation, it is worthwhile to look at the stocks of two Canadian marijuana producers, Organigram Holdings (OGI) and CannTrust (CTST).

Organigram

Organigram may have been a bit late when it comes to listing on a United States stock exchange but the company has had an excellent run in the market once it did. One of the most compelling reasons behind Organigram’s is the company’s low production costs and at the end of the day, investors will always be attracted to a company that can maintain such margins. Additionally, it is also set to raise its production capacity extensively this year.

Organigram expects to produce 113,000 kilos of marijuana this year, up from 47,000 kilos a year on average over the past years. Moreover, it has also been able to ink supply agreements with 10 major provinces in Canada and has also created an international footprint through its partnership with Alpha in Germany. Organigram is also making ground to enter the cannabis edibles market in a big way next year.

CannTrust

On the other hand, CannTrust is a highly interesting company and has been one of the bigger players in the medical marijuana market in Canada. More importantly, the company has also delivered exceptional growth in terms of the number of patients it services. In Q1 2019, the company reported a 70% year on year rise in patient growth.

More importantly, CannTrust has inked supply agreements with 9 states in Canada and due to its partnership with National Access Cannabis, the company’s products will reach an even bigger base of patients in the near future. It has also projected that it is going to produce 50,000 kilos of product a year from the next quarter onwards and it will go up once the Niagara facility expansion is completed. Last but not least, the company has also forayed into international markets through partnerships in Australia and Denmark.

According to experts, Organigram has grown quite rapidly, while CannTrust’s market cap is far smaller and hence could provide a bigger upside in the foreseeable future.

Published at Thu, 13 Jun 2019 19:53:42 +0000

Kroger to Sell CBD Products In 17 States

Kroger to Sell CBD Products In 17 States

eCann Media is proud to showcase our portfolio of investments and subsidiaries. We have completed numerous investments across multiple verticals and sectors in the cannabis industry. Requesting an invitation will enable the eCann team to consider your eligibility for investment as well help us to identify the opportunities that best fit your needs and investment objectives.

Published at Wed, 12 Jun 2019 21:00:00 +0000

The Woman Behind the Scenes at Cannabis’ Biggest Private Equity Fund

The Woman Behind the Scenes at Cannabis’ Biggest Private Equity Fund

eCann Media is proud to showcase our portfolio of investments and subsidiaries. We have completed numerous investments across multiple verticals and sectors in the cannabis industry. Requesting an invitation will enable the eCann team to consider your eligibility for investment as well help us to identify the opportunities that best fit your needs and investment objectives.

Published at Thu, 13 Jun 2019 12:00:00 +0000

Nevada Bans Pre-Employment Marijuana Tests

Nevada Bans Pre-Employment Marijuana Tests

The times they are a changing.

– Bob Dylan

Once upon a time, prospective employees submitting to marijuana testing faced a grim outcome if they were cannabis consumers. A positive result meant the door automatically slamming in their face.

That is no longer the situation in the state of Nevada, with a few limited exceptions. Nevada has become the first U.S. state to ban pre-employment marijuana tests as a basis for refusing employment to an applicant. More specifically:

AB 132, signed by Governor Steve Sisolak, makes it unlawful for any Nevada employer to fail or refuse to hire someone if they test positive for marijuana.

Drug screening is still allowed, since there is no prohibition on testing prospective employees for other drugs. However, it’s unlawful for employers to refuse to hire someone because of a positive test for marijuana.

In addition, prospective employees are permitted to take a second drug test, within a 30-day period. The cost for the second test would be borne by the applicant.

The Seed Investor has been monitoring the changing political attitudes in the U.S. with respect to the anti-cannabis policies of many public and private sector employers. These attitudes are also changing at the federal level, despite cannabis’ continued official status as a Schedule 1 drug (equated with heroin).

TSI reported on Monday that a congressional committee is urging employers across the nation to “reconsider hiring and firing policies” regarding marijuana, in those states where employees are in compliance with state cannabis laws.

Such anti-cannabis policies by employers affect 10’s of millions of employees across the U.S. (and Canada), cutting off that significant segment of the population from becoming consumers of legal cannabis.

No one is advocating cannabis use in the workplace. And cannabis users don’t need to take “smoke breaks” during the day (like those addicted to nicotine), since cannabis is non-addictive.

States across the United States are steadily approving the use of cannabis. This opens up opportunities for entrepreneurs and investors alike. But that opportunity cannot be fully exploited if a large chunk of the adult population is still shut off from cannabis use because of anti-cannabis policies at work.

To paraphrase a famous quote, today’s news is one giant leap for cannabis in Nevada, one small step for cannabis investors. But it’s a start.

Published at Wed, 12 Jun 2019 20:15:48 +0000

Leafbuyer Technologies Inc. (OTCMKTS:LBUY) Plans To Acquire Trade Show CBD.io

Leafbuyer Technologies Inc. (OTCMKTS:LBUY) Plans To Acquire Trade Show CBD.io

Leafbuyer
Technologies Inc. (OTCMKTS:LBUY)
has announced the signing of a non-binding letter of intent for the
acquisition of majority interest in CBD.io a trade show operation based in Las
Vegas. CBD.io runs one of the biggest and most evident expos in the Vape and
CBD industries.

Leafbuyer
to leverage CBD.io’s financial model for profitability

The agreement also includes an ownership interest
in an e-commerce platform for the retail and wholesale sale of CBD. CBD is a
non-psychoactive cannabinoid that is prevalent in cannabis that research has
shown can help in relieving anxiety, pain as well as other ailments.

Leafbuyer Technologies CEO Kurt Rossner
said that CBD is growing to become a widespread phenomenon in pop culture whose
trade indicates that the industry is productive and still unsaturated. He added
that that CBD.io is a company that is profitable and has demonstrated that its
financial model can increase the company’s top line and thus help in growing
Leafbuyer’s earnings.

Rossner said that the upside of the
acquisition is the capability for Leafbuyer gaining incredible brand exposure
from one of the fastest growing segments in the cannabis industry. In 2019
CBD.io sold close to 200 booths, and in 2019 the company plans to cross-sell
the platform to more than 400 clients a figure they will expect to double.

Leafbuyer
positioned to offer clients more value

The CEO asserted that the company is well
positioned to offer its customers a true 360 solution. Leafbuyer’s product
clients can get access to millions of potential consumers through the in-person
and digital methods to whom they can create brand awareness and thus increase
profits.

CBD.io CEO Robb Hackett stated that last
year the company hosted one of the biggest and most successful CBD and hemp
industry expos in the US. He added that in 2019, the company is expanding its
reach with a focus on educational series and more speakers as well as host
almost double the booths and offer clients more value in the trade shows. Currently,
CBD is a hot product in the US and focus in now to expand trade shows to Asia
and Europe by 2020.

Published at Tue, 11 Jun 2019 12:01:41 +0000

Latest IONIC Brands Deal Merits Closer Look

Latest IONIC Brands Deal Merits Closer Look

The Seed Investor has already alerted investors to the newest acquisition by U.S.-based IONIC Brands, billed as (perhaps) “the most important yet.” Here’s why investors may want to dig deeper.

Earlier today in a TSI Exclusive, we shone the spotlight on cannabis extraction specialists. TSI noted that at present, the best opportunities appeared to lie with some of the large-scale extraction specialists based in Canada.

Why extraction?

The cannabis industry is currently hampered (primarily) by two obstacles: over-regulation and bureaucratic inefficiency. This is both delaying the commercialization of cannabis and adding to the costs of doing business.

This eats into margins at both the wholesale (cultivation) and retail ends of the industry. Largely immune to these issues are intermediate segments of the industry like cannabis extraction. Charts for companies like MediPharm Labs and Valens GroWorks illustrate this potential.

Those aren’t the only segments of the cannabis industry at least partially sheltered from the issues previously mentioned. Manufacturers/suppliers of high-margin cannabis accessories are also positioned to enjoy maximum upside with minimum headaches.

Only last week, TSI pointed to another emerging trend in the cannabis industry. The Canadian cannabis industry is looking south for suppliers of vaporizers, vape pens, and related accessories.

Canada is preparing for Phase 2 of its national cannabis legalization. This includes introducing cannabis edibles and other infused products, as well as vape pens, vaporizers, and other accessories.

Canadian companies need to stock up. Here U.S.-based companies have the advantage. With markets for such products having been legalized earlier, U.S. companies boast the brands, the expertise, and the scale to move in.

This leads back to IONIC Brands Corp. (CAN: IONC, US: ZRRRF, FRA: IB3).

IONIC is a vertically-integrated multi-state operator (MSO). Its strong brands portfolio is spread across several U.S. states, including California, Washington State, and (now) Nevada. But in particular, the Company is heavy in vaporizer brands.
 

(IONIC’s line of premium vaporizers, #1 in Washington State)

Then there is today’s announcement: closing on the acquisition of Vegas Valley Growers (VVG).

IONIC’s acquisition of Vegas Valley Growers, based in Nevada, adds to the Company’s vertically-integrated, multi-state assets. Exciting news.

Nevada is projected as a huge cannabis market in 2019 (US$400 million). In just the first half of 2018, Nevada logged more cannabis revenues (US$195 million) than Washington State (US$67 million) and Colorado (US$114 million) combined.

Headlining VVG’s product line is the “Vegas M Stick”. An established Nevada vape pen brand, estimated 2019 U.S. revenues for this one product alone are $6.6 million. This also sets up IONIC to look north.

Today’s announcement is a two-for-one for investors.

IONIC Brands has established a significant presence in one of the U.S.’s most dynamic cannabis markets, Nevada, and added to its brands portfolio. Much like it did in California with its April 2019 deal with Origin House.

IONIC is also now a more attractive partner for Canadian-based cannabis companies looking to the U.S. for established and successful vaporizers/vape pens.

 
DISCLOSURE: IONIC Brands is a paid client of The Seed Investor.
 

Published at Wed, 12 Jun 2019 22:37:24 +0000




Your subscription could not be saved. Please try again.



Your subscription has been successful.

Subscribe now

Subscribe to our newsletter and stay updated.